Long-term benefits versus side-effects from bone-targeted therapies for cancer patients: minimizing risk while maximizing benefits.

Jacobs, Carmel

Long-term benefits versus side-effects from bone-targeted therapies for cancer patients: minimizing risk while maximizing benefits. [electronic resource] - Current opinion in supportive and palliative care Dec 2014 - 420-8 p. digital

Publication Type: Journal Article; Review

1751-4266

10.1097/SPC.0000000000000084 doi


Antibodies, Monoclonal, Humanized--therapeutic use
Biomarkers
Bisphosphonate-Associated Osteonecrosis of the Jaw
Bone Density Conservation Agents--administration & dosage
Bone Neoplasms--drug therapy
Bone and Bones--pathology
Breast Neoplasms--drug therapy
Denosumab
Diphosphonates--administration & dosage
Female
Humans
Palliative Care
Patient Selection
Quality of Life
Risk Factors